Следене
Fei Zhao
Fei Zhao
National Cancer Institute
Потвърден имейл адрес: nih.gov
Заглавие
Позовавания
Позовавания
Година
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
XJ Wang, Z Sun, NF Villeneuve, S Zhang, F Zhao, Y Li, W Chen, X Yi, ...
Carcinogenesis 29 (6), 1235-1243, 2008
9352008
A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62
A Lau, XJ Wang, F Zhao, NF Villeneuve, T Wu, T Jiang, Z Sun, E White, ...
Molecular and cellular biology 30 (13), 3275-3285, 2010
8592010
Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis
T Wu, F Zhao, B Gao, C Tan, N Yagishita, T Nakajima, PK Wong, ...
Genes & development 28 (7), 708-722, 2014
3272014
High levels of Nrf2 determine chemoresistance in type II endometrial cancer
T Jiang, N Chen, F Zhao, XJ Wang, B Kong, W Zheng, DD Zhang
Cancer research 70 (13), 5486-5496, 2010
3162010
Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization
F Zhao, C Xiao, KS Evans, T Theivanthiran, N DeVito, A Holtzhausen, ...
Immunity 48 (1), 147-160. e7, 2018
2122018
Melanoma-derived Wnt5a promotes local dendritic-cell expression of IDO and immunotolerance: opportunities for pharmacologic enhancement of immunotherapy
A Holtzhausen, F Zhao, KS Evans, M Tsutsui, C Orabona, DS Tyler, ...
Cancer immunology research 3 (9), 1082-1095, 2015
1642015
The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease
AD Lake, P Novak, RN Hardwick, B Flores-Keown, F Zhao, WT Klimecki, ...
Toxicological Sciences 137 (1), 26-35, 2014
1632014
KPNA6 (Importin α7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response
Z Sun, T Wu, F Zhao, A Lau, CM Birch, DD Zhang
Molecular and cellular biology 31 (9), 1800-1811, 2011
1282011
Nrf2 promotes neuronal cell differentiation
F Zhao, T Wu, A Lau, T Jiang, Z Huang, XJ Wang, W Chen, PK Wong, ...
Free Radical Biology and Medicine 47 (6), 867-879, 2009
1222009
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGF-β Inhibitor Sequencing in Melanoma
F Zhao, KS Evans, C Xiao, N DeVito, B Theivanthiran, A Holtzhausen, ...
Cancer Immunology Research, 2018
892018
Culture conditions profoundly impact phenotype in BEAS‐2B, a human pulmonary epithelial model
F Zhao, WT Klimecki
Journal of Applied Toxicology 35 (8), 945-951, 2015
752015
Arsenic exposure induces the Warburg effect in cultured human cells
F Zhao, P Severson, S Pacheco, BW Futscher, WT Klimecki
Toxicology and applied pharmacology 271 (1), 72-77, 2013
732013
Arsenite-induced autophagy is associated with proteotoxicity in human lymphoblastoid cells
AM Bolt, F Zhao, S Pacheco, WT Klimecki
Toxicology and applied pharmacology 264 (2), 255-261, 2012
402012
Arsenite-Induced Pseudo-Hypoxia Results in Loss of Anchorage-Dependent Growth in BEAS-2B Pulmonary Epithelial Cells
F Zhao, SW Malm, AN Hinchman, H Li, CG Beeks, WT Klimecki
PLOS ONE 9 (12), e114549, 2014
242014
Early carcinogenesis involves the establishment of immune privilege via intrinsic and extrinsic regulation of indoleamine 2, 3-dioxygenase-1: translational implications in …
A Holtzhausen, F Zhao, KS Evans, BA Hanks
Frontiers in immunology 5, 111927, 2014
152014
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016
A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ...
Journal for immunotherapy of cancer 4, 1-106, 2016
102016
Targeting the Wnt5a-β-catenin pathway in the melanoma microenvironment to augment checkpoint inhibitor immunotherapy.
BA Hanks, F Zhao, K Evans, A Holtzhausen, M Tsutsui, D Tyler
Journal of Clinical Oncology 33 (15_suppl), 3054-3054, 2015
32015
Running interference on miR-33: a new amplification loop for type I interferon in the host antiviral response
F Zhao, MB Fessler
Cellular & Molecular Immunology 17 (10), 1109-1110, 2020
12020
Composition of matter and methods for alteration of dendritic cell metabolism to augment cancer vaccine efficacy
B Hanks, F Zhao
US Patent 10,617,749, 2020
12020
Predictive biomarkers for cancer immunotherapy and methods of using same
B Hanks, N Devito, B Theivanthiran, F Zhao
US Patent 11,643,691, 2023
2023
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20